Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to evaluate the efficacy and safety of ramucirumab or merestinib or placebo plus cisplatin and gemcitabine in participants with advanced or metastatic biliary tract cancer.
Official title: Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment in Patients With Advanced or Metastatic Biliary Tract Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
309
Start Date
2016-05-19
Completion Date
2026-12
Last Updated
2025-08-03
Healthy Volunteers
No
Interventions
Ramucirumab
Administered IV
Merestinib
Administered orally
Cisplatin
Administered IV
Gemcitabine
Administered IV
Placebo Oral
Administered orally
Placebo IV
Administered IV
Locations (82)
The University of Arizona Cancer Center
Tucson, Arizona, United States
UCSF Medical Center at Mission Bay
San Francisco, California, United States
Georgetown University Medical Center
Washington D.C., District of Columbia, United States
University of Florida School of Medicine
Gainesville, Florida, United States
Karmanos Cancer Institute
Detroit, Michigan, United States
Washington University Medical School
City of Saint Peters, Missouri, United States
Washington University Medical School
Creve Coeur, Missouri, United States
Washington University Medical School
St Louis, Missouri, United States
Washington University Medical School
St Louis, Missouri, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Florida Cancer Specialists
Nashville, Tennessee, United States
Tennessee Oncology PLLC
Nashville, Tennessee, United States
Alexander Fleming
CABA, BS, Argentina
Hospital de Gastroenterologia Udaondo
Capital Federal, Buenos Aires, Argentina
Fundacion Ars Medica
San Salvador de Jujuy, Jujuy Province, Argentina
Clinica Viedma
Viedma, Río Negro Province, Argentina
Centro Medico San Roque
San Miguel de Tucumán, Tucumán Province, Argentina
Fundacion Favaloro
Ciudad de Buenos Aires, Argentina
Fundación CORI para la Investigación y Prevención del Cáncer
La Rioja, Argentina
Centro Polivalente de Asistencia e Inv. Clinica CER-San Juan
San Juan, Argentina
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Austin Health
Heidelberg, Victoria, Australia
Landesklinikum Wr. Neustadt
Wiener Neustadt, Lower Austria, Austria
Universitätsklinikum Salzburg
Salzburg, Austria
KH der Barmherzigen Brüder Wien
Vienna, Austria
Cliniques universitaires Saint-Luc
Brussels, Brussels Capital, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
Leuven, Belgium
Masarykuv onkologicky ustav
Brno, Brno-město, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, Czechia
Fakultni Nemocnice v Motole
Prague, Czechia
Aarhus Universitetshospital, Aarhus Sygehus
Aarhus C, Denmark
Odense Universitetshospital
Odense C, Denmark
Centre Leon Berard
Lyon, Auvergne-Rhône-Alpes, France
CHU de Bordeaux Hop St ANDRE
Bordeaux, Gironde, France
CHU de Besancon Hopital Jean Minjoz
Besançon, France
Hôpital C. HURIEZ
Lille, France
CHRU de Montpellier-Hopital St Eloi
Montpellier, France
Centre Antoine-Lacassagne
Nice, France
Gustave Roussy
Villejuif, France
Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany
Universitätsklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
Universitätsklinikum Erlangen
Erlangen, Bavaria, Germany
Medizinische Hochschule Hanover
Hanover, Lower Saxony, Germany
HELIOS Klinikum Berlin-Buch
Berlin, Germany
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, Germany
Debreceni Egyetem Klinikai Kozpont Onkologiai Tanszek
Debrecen, Hajdú-Bihar, Hungary
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet
Budapest, Hungary
Arke Estudios Clinicos S.A. de C.V.
Mexico City, Mexico City, Mexico
Centro de Alta Especialidad Reumatologia Inv del Potosi SC
San Luis Potosí City, Mexico
Russian Scientific Center of Radiology and Surgical Technologies
Saint Petersburg, Sankt-Peterburg, Russia
Arkhangelsk Clinical Oncological Dispensary
Arkhangelsk, Russia
Blokhin Cancer Research Center
Moscow, Russia
Saint-Petersburg City Clinical Oncology Dispensary
Saint Petersburg, Russia
Asan Medical Center
Seoul, Korea, South Korea
Seoul National University Hospital
Seoul, Seoul, Korea, South Korea
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Hospital Duran I Reynals
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Clínico Universitario de Valencia
Barcelona, Spain
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Hospital Clinico de San Carlos
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Skåne universitetssjukhus
Malmo, Sweden
Karolinska Universitetssjukhuset i Solna
Stockholm, Sweden
Chang Gung Memorial Hospital - Kaohsiung Branch
Kaohsiung City, Taiwan
China Medical University Hospital
Taichung, Taiwan
National Cheng-Kung Uni. Hosp.
Tainan, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Chang Gung Memorial Hospital - Linkou
Taoyuan, Taiwan
Baskent University Dr. Turgut Noyan Research and Training Center
Adana, Turkey (Türkiye)
Hacettepe University Faculty of Medicine
Ankara, Turkey (Türkiye)
Akdeniz University Medical Faculty
Antalya, Turkey (Türkiye)
Trakya University
Edirne, Turkey (Türkiye)
Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi Yerleskesi
Istanbul, Turkey (Türkiye)
University College Hospital - London
London, Greater London, United Kingdom
The Christie NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom
Hammersmith Hospital
Acton, London, United Kingdom
The Clatterbridge Cancer Centre
Bebbington, Merseyside, United Kingdom
Royal Marsden Hospital
Sutton, Surrey, United Kingdom